Related references
Note: Only part of the references are listed.Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM
Tobias Lanz et al.
NATURE (2022)
Longitudinal Analysis Suggests Epstein--Barr as Cause of Multiple Sclerosis
[Anonymous]
CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)
Do Epstein-Barr Virus Mutations and Natural Genome Sequence Variations Contribute to Disease?
Paul J. Farrell et al.
BIOMOLECULES (2022)
High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia
Blachy J. Davila Saldana et al.
BLOOD ADVANCES (2022)
EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2022 update on diagnosis, risk-stratification, and management
Luis Malpica et al.
AMERICAN JOURNAL OF HEMATOLOGY (2022)
Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
Wiyada Wongwiwat et al.
JOURNAL OF VIROLOGY (2022)
A bivalent Epstein-Barr virus vaccine induces neutralizing antibodies that block infection and confer immunity in humanized mice
Chih-Jen Wei et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cells
Jillian A. Bristol et al.
PLOS PATHOGENS (2022)
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
Kjetil Bjornevik et al.
SCIENCE (2022)
BHRF1, a BCL2 viral homolog, disturbs mitochondrial dynamics and stimulates mitophagy to dampen type I IFN induction
Geraldine Vilmen et al.
AUTOPHAGY (2021)
Molecular biology of Hodgkin lymphoma
Marc A. Weniger et al.
LEUKEMIA (2021)
The Epstein-Barr virus noncoding RNA EBER2 transactivates the UCHL1 deubiquitinase to accelerate cell growth
Zhe Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
The Epstein-Barr Virus Oncogene EBNA1 Suppresses Natural Killer Cell Responses and Apoptosis Early after Infection of Peripheral B Cells
Danielle Westhoff Smith et al.
MBIO (2021)
ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells
Nicholas Van Sciver et al.
PLOS PATHOGENS (2021)
Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-κB activation and immune escape
Jeff P. Bruce et al.
NATURE COMMUNICATIONS (2021)
Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells
Nicholas Van Sciver et al.
PLOS PATHOGENS (2021)
Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified
Estelle Bourbon et al.
BLOOD ADVANCES (2021)
Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation
Susan Prockop et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Epstein-Barr virus NK and T cell lymphoproliferative disease: report of a 2018 international meeting
Jeffrey I. Cohena et al.
LEUKEMIA & LYMPHOMA (2020)
A promiscuous inflammasome sparks replication of a common tumor virus
Eric M. Burton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Epstein-Barr virus co-opts TFIIH component XPB to specifically activate essential viral lytic promoters
Dinesh Verma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Suppresses Type I Interferon Signaling To Promote EBV Reactivation
XueQiao Liu et al.
JOURNAL OF VIROLOGY (2020)
CD21 (Complement Receptor 2) Is the Receptor for Epstein-Barr Virus Entry into T Cells
Nicholas A. Smith et al.
JOURNAL OF VIROLOGY (2020)
MYC Controls the Epstein-Barr Virus Lytic Switch
Rui Guo et al.
MOLECULAR CELL (2020)
DNA methylation enzymes and PRC1 restrict B-cell Epstein-Barr virus oncoprotein expression
Rui Guo et al.
NATURE MICROBIOLOGY (2020)
EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice
Chunrong Li et al.
PLOS PATHOGENS (2020)
The Role of EBV-Induced Hypermethylation in Gastric Cancer Tumorigenesis
Lyla J. Stanland et al.
VIRUSES-BASEL (2020)
Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas
Keisuke Kataoka et al.
LEUKEMIA (2019)
Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth
Troy E. Messick et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells
Wei Bu et al.
IMMUNITY (2019)
Successful preemptive therapy with single-dose rituximab for Epstein-Barr virus infection to prevent post-transplant lymphoproliferative disease after pediatric hematopoietic stem cell transplantation
Bo Kyung Kim et al.
TRANSPLANT INFECTIOUS DISEASE (2019)
Epstein-Barr virus ncRNA from a nasopharyngeal carcinoma induces an inflammatory response that promotes virus production
Zhe Li et al.
NATURE MICROBIOLOGY (2019)
Epithelial cell infection by Epstein-Barr virus
Jia Chen et al.
FEMS MICROBIOLOGY REVIEWS (2019)
Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with VirusInfected Cells: Clue for a Virus-Driven Immunopathological Mechanism
Barbara Serafini et al.
JOURNAL OF VIROLOGY (2019)
14-3-3 scaffold proteins mediate the inactivation of trim25 and inhibition of the type I interferon response by herpesvirus deconjugases
Soham Gupta et al.
PLOS PATHOGENS (2019)
MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control In Vivo
Anita Murer et al.
MBIO (2019)
Epstein-Barr virus BORF2 inhibits cellular APOBEC3B to preserve viral genome integrity
Adam Z. Cheng et al.
NATURE MICROBIOLOGY (2019)
Defective Epstein-Barr virus in chronic active infection and haematological malignancy
Yusuke Okuno et al.
NATURE MICROBIOLOGY (2019)
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma
Enrico Tiacci et al.
BLOOD (2018)
Epstein-Barr virus and rheumatoid arthritis
Nathalie Balandraud et al.
JOINT BONE SPINE (2018)
Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity
John B. Harley et al.
NATURE GENETICS (2018)
Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
Seung Tae Kim et al.
NATURE MEDICINE (2018)
Ephrin receptor A2 is a functional entry receptor for Epstein-Barr virus
Jia Chen et al.
NATURE MICROBIOLOGY (2018)
A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection
Jillian A. Bristol et al.
PLOS PATHOGENS (2018)
Viral unmasking of cellular 5S rRNA pseudogene transcripts induces RIG-I-mediated immunity
Jessica J. Chiang et al.
NATURE IMMUNOLOGY (2018)
Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and γδ T cells
Zakia Djaoud et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Epstein-Barr Virus miR-BART6-3p Inhibits the RIG-I Pathway
Yuanjun Lu et al.
JOURNAL OF INNATE IMMUNITY (2017)
Viral effects on the content and function of extracellular vesicles
Nancy Raab-Traub et al.
NATURE REVIEWS MICROBIOLOGY (2017)
Tumour virus epidemiology
Ruth M. Lunn et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2017)
Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency
Gina Pisano et al.
VIROLOGY JOURNAL (2017)
TRIM29 promotes DNA virus infections by inhibiting innate immune response
Junji Xing et al.
NATURE COMMUNICATIONS (2017)
EBV epigenetically suppresses the B cell-to-plasma cell differentiation pathway while establishing long-term latency
Christine T. Styles et al.
PLOS BIOLOGY (2017)
An essential EBV latent antigen 3C binds Bcl6 for targeted degradation and cell proliferation
Yonggang Pei et al.
PLOS PATHOGENS (2017)
Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus's natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter
Richard J. Kraus et al.
PLOS PATHOGENS (2017)
Chloroquine triggers Epstein-Barr virus replication through phosphorylation of KAP1/TRIM28 in Burkitt lymphoma cells
Xiaofan Li et al.
PLOS PATHOGENS (2017)
Epstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infection
Alexander M. Price et al.
ELIFE (2017)
The Missing Link in Epstein-Barr Virus Immune Evasion: the BDLF3 Gene Induces Ubiquitination and Downregulation of Major Histocompatibility Complex Class I (MHC-I) and MHC-II
Laura L. Quinn et al.
JOURNAL OF VIROLOGY (2016)
The cGAS-STING Defense Pathway and Its Counteraction by Viruses
Zhe Ma et al.
CELL HOST & MICROBE (2016)
Epstein-Barr virus nuclear protein EBNA3C directly induces expression of AID and somatic mutations in B cells
Jens S. Kalchschmidt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Hodgkin lymphoma: Pathology and biology
Stephan Mathas et al.
SEMINARS IN HEMATOLOGY (2016)
An Epstein-Barr Virus-Encoded Protein Complex Requires an Origin of Lytic Replication In Cis to Mediate Late Gene Transcription
Reza Djavadian et al.
PLOS PATHOGENS (2016)
NK Cell Influence on the Outcome of Primary Epstein-Barr Virus Infection
Obinna Chijioke et al.
FRONTIERS IN IMMUNOLOGY (2016)
The immunology of Epstein-Barr Virus Induced Disease
Graham S. Taylor et al.
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
Nasopharyngeal carcinoma progression is mediated by EBER-triggered inflammation via the RIG-I pathway
Yumei Duan et al.
CANCER LETTERS (2015)
Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript Region
Aron R. Marquitz et al.
JOURNAL OF VIROLOGY (2015)
Epstein-Barr Virus Latent Membrane Protein 2 Induces Autophagy To Promote Abnormal Acinus Formation
Julie A. Fotheringham et al.
JOURNAL OF VIROLOGY (2015)
Changes in Expression Induced by Epstein-Barr Virus LMP1-CTAR1: Potential Role of bcl3
Rachel Hood Edwards et al.
MBIO (2015)
Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells
Hong-Bo Wang et al.
NATURE COMMUNICATIONS (2015)
Differentiation-Dependent KLF4 Expression Promotes Lytic Epstein-Barr Virus Infection in Epithelial Cells
Dhananjay M. Nawandar et al.
PLOS PATHOGENS (2015)
Early-life exposures to infectious agents and later cancer development
Vidya Vedham et al.
CANCER MEDICINE (2015)
Prevalence and Clinical Implications of Epstein-Barr Virus Infection in De Novo Diffuse Large B-Cell Lymphoma in Western Countries
Chi Young Ok et al.
CLINICAL CANCER RESEARCH (2014)
A Genetic Basis for Infectious Mononucleosis: Evidence From a Family Study of Hospitalized Cases in Denmark
Klaus Rostgaard et al.
CLINICAL INFECTIOUS DISEASES (2014)
Expression Profile of MicroRNAs in Epstein-Barr Virus-Infected AGS Gastric Carcinoma Cells
Aron R. Marquitz et al.
JOURNAL OF VIROLOGY (2014)
Epstein-Barr Virus Glycoprotein gB and gHgL Can Mediate Fusion and Entry in trans, and Heat Can Act as a Partial Surrogate for gHgL and Trigger a Conformational Change in gB
Liudmila S. Chesnokova et al.
JOURNAL OF VIROLOGY (2014)
A Single Amino Acid in EBNA-2 Determines Superior B Lymphoblastoid Cell Line Growth Maintenance by Epstein-Barr Virus Type 1 EBNA-2
Stelios Tzellos et al.
JOURNAL OF VIROLOGY (2014)
MicroRNA miR-BART20-5p Stabilizes Epstein-Barr Virus Latency by Directly Targeting BZLF1 and BRLF1
Yu-Jin Jung et al.
JOURNAL OF VIROLOGY (2014)
Epstein-Barr Virus Late Gene Transcription Depends on the Assembly of a Virus-Specific Preinitiation Complex
Valentin Aubry et al.
JOURNAL OF VIROLOGY (2014)
Epstein-Barr virus maintains lymphomas via its miRNAs
D. T. Vereide et al.
ONCOGENE (2014)
Efficient replication of Epstein-Barr virus in stratified epithelium in vitro
Rachel M. Temple et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
RNA families in Epstein-Barr virus
Walter N. Moss et al.
RNA BIOLOGY (2014)
Regulation of the latent-lytic switch in Epstein-Barr virus
Shannon C. Kenney et al.
SEMINARS IN CANCER BIOLOGY (2014)
Cellular immune controls over Epstein-Barr virus infection: new lessons from the clinic and the laboratory
Alan B. Rickinson et al.
TRENDS IN IMMUNOLOGY (2014)
KSHV LANA and EBV LMP1 induce the expression of UCH-L1 following viral transformation
Gretchen L. Bentz et al.
VIROLOGY (2014)
A Multifactorial Role for P. falciparum Malaria in Endemic Burkitt's Lymphoma Pathogenesis
Charles Torgbor et al.
PLOS PATHOGENS (2014)
Epstein-Barr Virus Large Tegument Protein BPLF1 Contributes to Innate Immune Evasion through Interference with Toll-Like Receptor Signaling
Michiel van Gent et al.
PLOS PATHOGENS (2014)
Innate immune control of EBV-infected B cells by invariant natural killer T cells
Brian K. Chung et al.
BLOOD (2013)
Epstein-Barr Viral Productive Amplification Reprograms Nuclear Architecture, DNA Replication, and Histone Deposition
Ya-Fang Chiu et al.
CELL HOST & MICROBE (2013)
EBV BILF1 Evolved To Downregulate Cell Surface Display of a Wide Range of HLA Class I Molecules through Their Cytoplasmic Tail
Bryan D. Griffin et al.
JOURNAL OF IMMUNOLOGY (2013)
Behavioral, Virologic, and Immunologic Factors Associated With Acquisition and Severity of Primary Epstein-Barr Virus Infection in University Students
Henry H. Balfour et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Age-Specific Prevalence of Epstein-Barr Virus Infection Among Individuals Aged 6-19 Years in the United States and Factors Affecting Its Acquisition
Henry H. Balfour et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma
Grace Tin-Yun Chung et al.
JOURNAL OF PATHOLOGY (2013)
Viral Genome Methylation Differentially Affects the Ability of BZLF1 versus BRLF1 To Activate Epstein-Barr Virus Lytic Gene Expression and Viral Replication
Coral K. Wille et al.
JOURNAL OF VIROLOGY (2013)
Epstein-Barr Virus Deubiquitinase Downregulates TRAF6-Mediated NF-κB Signaling during Productive Replication
Shinichi Saito et al.
JOURNAL OF VIROLOGY (2013)
Human Complement Receptor Type 1/CD35 Is an Epstein-Barr Virus Receptor
Javier G. Ogembo et al.
CELL REPORTS (2013)
Differences in Gastric Carcinoma Microenvironment Stratify According to EBV Infection Intensity: Implications for Possible Immune Adjuvant Therapy
Michael J. Strong et al.
PLOS PATHOGENS (2013)
Epidemiology: clues to the pathogenesis of Burkitt lymphoma
Ian Magrath
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Cutting Edge: miR-223 and EBV miR-BART15 Regulate the NLRP3 Inflammasome and IL-1β Production
Moritz Haneklaus et al.
JOURNAL OF IMMUNOLOGY (2012)
Genome-wide siRNA screen for mediators of NF-κB activation
Benjamin E. Gewurz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The EBV Immunoevasins vIL-10 and BNLF2a Protect Newly Infected B Cells from Immune Recognition and Elimination
Simon Jochum et al.
PLOS PATHOGENS (2012)
TLRs innate immunereceptors and Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) CIDR1α-driven human polyclonal B-cell activation
Olivia Simone et al.
ACTA TROPICA (2011)
Lymphomas differ in their dependence on Epstein-Barr virus
David T. Vereide et al.
BLOOD (2011)
EBV Lytic-Phase Protein BGLF5 Contributes to TLR9 Downregulation during Productive Infection
Michiel van Gent et al.
JOURNAL OF IMMUNOLOGY (2011)
A New Model of Epstein-Barr Virus Infection Reveals an Important Role for Early Lytic Viral Protein Expression in the Development of Lymphomas
Shi-Dong Ma et al.
JOURNAL OF VIROLOGY (2011)
Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) C-Terminal-Activating Region 3 Contributes to LMP1-Mediated Cellular Migration via Its Interaction with Ubc9
Gretchen L. Bentz et al.
JOURNAL OF VIROLOGY (2011)
Enzymatic Blockade of the Ubiquitin-Proteasome Pathway
Robert Ernst et al.
PLOS BIOLOGY (2011)
EBV Tegument Protein BNRF1 Disrupts DAXX-ATRX to Activate Viral Early Gene Transcription
Kevin Tsai et al.
PLOS PATHOGENS (2011)
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
Helen E. Heslop et al.
BLOOD (2010)
EBV Latent Membrane Protein 1 Is a Negative Regulator of TLR9
Ikbal Fathallah et al.
JOURNAL OF IMMUNOLOGY (2010)
AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome
Markus Kalla et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Human tumor virus utilizes exosomes for intercellular communication
David G. Meckes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Functional delivery of viral miRNAs via exosomes
D. Michiel Pegtel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo
Leah J. Anderson et al.
BLOOD (2009)
Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells
Jihene Klibi et al.
BLOOD (2009)
Discerning regulation of cis- and trans-presentation of CD8+ T-cell epitopes by EBV-encoded oncogene LMP-1 through self-aggregation
Corey Smith et al.
BLOOD (2009)
EBV-Induced Human CD8+ NKT Cells Suppress Tumorigenesis by EBV-Associated Malignancies
He Yuling et al.
CANCER RESEARCH (2009)
RNA Polymerase III Detects Cytosolic DNA and Induces Type I Interferons through the RIG-I Pathway
Yu-Hsin Chiu et al.
CELL (2009)
The Effects of Acute Malaria on Epstein-Barr Virus (EBV) Load and EBV-Specific T Cell Immunity in Gambian Children
Ramou Njie et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Long-Term Administration of Valacyclovir Reduces the Number of Epstein-Barr Virus (EBV)-Infected B Cells but Not the Number of EBV DNA Copies per B Cell in Healthy Volunteers
Yo Hoshino et al.
JOURNAL OF VIROLOGY (2009)
RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate
Andrea Ablasser et al.
NATURE IMMUNOLOGY (2009)
The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation
K. M. Shah et al.
ONCOGENE (2009)
Toll-like receptor signaling controls reactivation of KSHV from latency
Sean M. Gregory et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Toll-like Receptor and RIG-1-like Receptor Signaling
Taro Kawai et al.
YEAR IN IMMUNOLOGY 2008 (2008)
EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-γ and IL-2
Jan D. Luenemann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival
Christoph Mancao et al.
BLOOD (2007)
Roles of lytic viral infection and IL-6 in early versus late passage lymphoblastoid cell lines and EBV-associated lymphoproliferative disease
Richard J. Jones et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Unique signaling properties of CTAR1 in LMP1-Mediated transformation
Bernardo A. Mainou et al.
JOURNAL OF VIROLOGY (2007)
Epstein-Barr virus induces MCP-1 secretion by human monocytes via TLR2
Eric Gaudreault et al.
JOURNAL OF VIROLOGY (2007)
Exposure to holoendemic malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in Kenyan children
Ann M. Moormann et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type IIFN
Mrinal Samanta et al.
EMBO JOURNAL (2006)
Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma
A Bräuninger et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Epstein-Barr virus MicroRNAs are evolutionarily conserved and differentially expressed
Xuezhong Cai et al.
PLOS PATHOGENS (2006)
Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus
BD Poole et al.
AUTOIMMUNITY (2006)
Epstein-Barr virus lytic infection is required for efficient production of the angiogenesis factor vascular endothelial growth factor in lymphoblastoid cell lines
GK Hong et al.
JOURNAL OF VIROLOGY (2005)
Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model
GK Hong et al.
JOURNAL OF VIROLOGY (2005)
Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100
PD Ling et al.
EMBO JOURNAL (2005)
CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells
VA Pudney et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo
LL Laichalk et al.
JOURNAL OF VIROLOGY (2005)
Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells
D Hochberg et al.
JOURNAL OF VIROLOGY (2004)
Identification of virus-encoded microRNAs
S Pfeffer et al.
SCIENCE (2004)
AID is required for c-myc/IgH chromosome translocations in vivo
AR Ramiro et al.
CELL (2004)
Differential signaling pathways are activated in the Epstein-Barr virus-associated malignancies nasopharyngeal carcinoma and Hodgkin lymphoma
JA Morrison et al.
CANCER RESEARCH (2004)
Epstein-Barr virus, arthritis, and the development of lymphoma in arthritis patients
MFC Callan
CURRENT OPINION IN RHEUMATOLOGY (2004)
The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome
PM Bhende et al.
NATURE GENETICS (2004)
Epstein-Barr virus latent membrane protein 1 activation of NF-κB through IRAK1 and TRAF6
M Luftig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Epstein-Barr virus provides a survival factor to Burkitt's lymphomas
G Kennedy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
An epidemiologic study of index and family infectious mononucleosis and adult Hodgkin's disease (HD):: Evidence for a specific association with EBV+ve HD in young adults
FE Alexander et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Characteristics of Hodgkin's lymphoma after infectious mononucleosis
H Hjalgrim et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1
Y Yin et al.
SCIENCE (2003)
A novel function for the Epstein-Barr virus transcription factor EB1/Zta: induction of transcription of the hIL-10 gene
S Mahot et al.
JOURNAL OF GENERAL VIROLOGY (2003)
The CBP bromodomain and nucleosome targeting are required for Zta-directed nucleosome acetylation and transcription activation
Z Deng et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Prognostic factors for chronic active Epstein-Barr virus infection
H Kimura et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus
CM Borza et al.
NATURE MEDICINE (2002)
The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators
R Feederle et al.
EMBO JOURNAL (2000)
Share Paper
